Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. List of pharmaceutical manufacturers in the United Kingdom

    en.wikipedia.org/wiki/List_of_pharmaceutical...

    LEO – LEO Pharma. LifeScan – LifeScan. Lilly – Eli Lilly and Company Ltd. Lundbeck – Lundbeck Ltd. Martindale Pharma – Martindale Pharmaceuticals - Ltd (Now Ethypharm UK) Mölnlycke – Mölnlycke Health Care Ltd. Mayne – Mayne Pharma plc. McNeil – McNeil Laboratories Ltd. Meda – Meda Pharmaceuticals Ltd.

  3. Marion Merrell Dow - Wikipedia

    en.wikipedia.org/wiki/Marion_Merrell_Dow

    Marion Merrell Dow and its predecessor Marion Laboratories was a U.S. pharmaceutical company based in Kansas City, Missouri, from 1950 until 1996.. The company specialized in bringing to market drugs that had been discovered but unmarketed by other companies including Cardizem which treats arrhythmias and high blood pressure, Carafate (an ulcer treatment), Gaviscon (an antacid), Seldane (a ...

  4. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

  5. Sanofi's consumer healthcare spin-off attracts private ... - AOL

    www.aol.com/news/sanofis-consumer-healthcare...

    The news comes months after Sanofi announced it was reviewing "separation scenarios" for the unit in a bid to focus on its core innovative drugs business. Sanofi's consumer healthcare spin-off ...

  6. Sanofi loses $21 billion in market value after dropping 2025 ...

    www.aol.com/news/sanofi-considering-consumer...

    By Ludwig Burger. (Reuters) -Sanofi stock plunged on Friday, wiping 20 billion euros ($21 billion) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer ...

  7. Sanofi hails drug hopefuls in wake of stock slump - AOL

    www.aol.com/news/sanofi-focus-12-blockbuster...

    By Ludwig Burger and Anirudh Saligrama. (Reuters) -Sanofi vaunted 12 drugs in development with the potential to make more than $1 billion in annual sales, but failed to reverse a recent plunge in ...

  8. Paul Hudson (businessman) - Wikipedia

    en.wikipedia.org/wiki/Paul_Hudson_(businessman)

    CEO, Sanofi. Term. September 2019-. Predecessor. Olivier Brandicourt. Children. 3. Paul Hudson (born 14 October 1967) [ 2] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales. [ 3]

  9. Fexofenadine - Wikipedia

    en.wikipedia.org/wiki/Fexofenadine

    Fexofenadine. Fexofenadine, sold under the brand name Allegra among others, [10] is an antihistamine pharmaceutical drug used in the treatment of allergy symptoms, such as hay fever and urticaria. [11] Therapeutically, fexofenadine is a selective peripheral H 1 blocker. It is classified as a second-generation antihistamine because it is less ...